Discriminative stimulus effects of nitrous oxide in mice: Comparison with volatile hydrocarbons and vapor anesthetics

Behavioural Pharmacology

Volumn 25, Issue 1, 2014, Pages 2-11

  Richardson, Kellianne J ^a   Shelton, Keith L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

analgesic; anesthetic; anxiolytic; drug discrimination; inhalants nitrous oxide; toluene

Indexed keywords

1,1,1 TRICHLOROETHANE; 2 BUTANOL; ALCOHOL; AROMATIC HYDROCARBON; CHLORINATED HYDROCARBON; DEXAMPHETAMINE; HYDROCARBON; INHALATION ANESTHETIC AGENT; ISOFLURANE; METHOXYFLURANE; NITROUS OXIDE; OXYGEN; TOLUENE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EXPOSURE; MALE; MOUSE; NONHUMAN; VAPOR;

ADMINISTRATION, INHALATION; ANESTHETICS; ANIMALS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCARBONS; MALE; MICE; NITROUS OXIDE;

EID: 84891862945     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000017     Document Type: Article

References (50)

1. AbdullahW, Sheta S, Nooh N (2011). Inhaled methoxyflurane (Penthrox) sedation for third molar extraction: a comparison to nitrous oxide sedation. Aust Dent J 56:296-301.
2. Balster R (1998). Neural basis of inhalant abuse. Drug Alcohol Depend 51: 207-214. (Pubitemid 28353768)
3. Balster R, Cruz S, Howard M, Dell C, Cottler L (2009). Classification of abused inhalants. Addiction 104:878-882.
4. Beckman NJ, Zacny JP, Walker DJ (2006). Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers. Drug Alcohol Depend 81:89-95. (Pubitemid 41682483)
5. Bell D, McDonough J, Ellison J, Fitzhugh E (1999). Controlled drug misuse by certified registered nurse anesthetists. AANA J 67:133-140. (Pubitemid 29204472)
6. Block R, Ghoneim M, Kumar V, Pathak D (1990). Psychedelic effects of a subanesthetic concentration of nitrous oxide. Anesth Prog 37:271.
7. Boehm SL, Reed CL, McKinnon CS, Phillips TJ (2002). Shared genes influence sensitivity to the effects of ethanol on locomotor and anxiety-like behaviors, and the stress axis. Psychopharmacology (Berl) 161:54-63. (Pubitemid 34437969)
8. Bowen SE, Wiley JL, Balster RL (1996a). The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur J Pharmacol 312:131-136. (Pubitemid 26325670)
9. Bowen SE, Wiley JL, Evans EB, Tokarz ME, Balster RL (1996b). Functional observational battery comparing effects of ethanol, 1, 1, 1-trichloroethane, ether, and flurothyl. Neurotoxicol Teratol 18:577-585. (Pubitemid 26346103)
10. Bowen S (2006). Increases in amphetamine-like discriminative stimulus effects of the abused inhalant toluene in mice. Psychopharmacology (Berl) 186: 517-524. (Pubitemid 43855838)
11. Caldicott DGE (2011). Methoxy-what?! Emerg Med J 28:726-726.
12. Cruz SL (2011). The latest evidence in the neuroscience of solvent misuse: an article written for service providers. Subst Use Misuse 46 (Suppl 1):62-67.
13. Dohrn C, Lichtor J, Finn R, Uitvlugt A, Coalson D, Rupani G, et al. (1992). Subjective and psychomotor effects of nitrous oxide in healthy volunteers. Behav Pharmacol 3:19-30.
14. Dohrn C, Lichtor J, Coalson D, Uitvlugt A, de Wit H, Zacny J (1993). Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend 31:265-280. (Pubitemid 23093395)
15. Emmanouil DE, Quock RM (2007). Advances in understanding the actions of nitrous oxide. Anesth Prog 54:9-18.
16. Garriott J, Petty C (1980). Death from inhalant abuse: toxicological and pathological evaluation of 34 cases. Clin Toxicol 16:305-315. (Pubitemid 10021120)
17. Grant K, Colombo G (1993). Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists. J Pharmacol Exp Ther 264:1241-1247. (Pubitemid 23318617)
18. Harrison Y, Jenkins J, Rocha B, Lytle D, Jung M, Oglesby M (1998). Discriminative stimulus effects of diazepam, ketamine and their mixture: ethanol substitution patterns. Behav Pharmacol 9:31-40. (Pubitemid 28098665)
19. Hathout L, El-Saden S (2011). Nitrous oxide-induced B12 deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B12. J Neurol Sci 301: 1-8.
20. Hwang J, Himel H, Edlich R (1996). Frostbite of the face after recreational misuse of nitrous oxide. Burns 22:152-153. (Pubitemid 26050874)
21. Hynes MD, Hymson DL (1984). Nitrous oxide generalizes to a discriminative stimulus produced by ethylketocyclazocine but not morphine. Eur J Pharmacol 105:155-159. (Pubitemid 14006346)
22. Järbe T, McMillan D (1983). Interaction of the discriminative stimulus properties of diazepam and ethanol in pigeons. Pharmacol Biochem Behav 18:73-80. (Pubitemid 13224587)
23. Kangas BD, Walker DJ (2008). An adjusting-dose procedure for assessing the reinforcing effects of nitrous oxide with humans. Pharmacol Biochem Behav 91:104-108.
24. Knisely J, Rees D, Balster R (1990). Discriminative stimulus properties of toluene in the rat. Neurotoxicol Teratol 12:129-133. (Pubitemid 20177168)
25. Lapin I (1993). Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol. Pharmacol Biochem Behav 44:241-243.
26. Laska M, Shepherd GM (2007). Olfactory discrimination ability of CD-1 mice for a large array of enantiomers. Neuroscience 144:295-301. (Pubitemid 44839037)
27. Mariathasan EA, Garcha HS, Stolerman IP (1991). Discriminative stimulus effects of amphetamine and pentobarbitone separately and as mixtures in rats. Behav Pharmacol 2:405-415.
28. National Research Council (2011). Guide for the care and use of laboratory animals. National Research Council: National Academy Press.
29. Overton D (1982). Multiple drug training as a method for increasing the specificity of the drug discrimination procedure. J Pharmacol Exp Ther 221:166-172. (Pubitemid 12156488)
30. Overton D, Shen C, Ke G, Gazdick L (1989). Discriminable effects of phencyclidine analogs evaluated by multiple drug (PCP versus OTHER) discrimination training. Psychopharmacology (Berl) 97:514-520. (Pubitemid 19102555)
31. Potocka-Banas B, Majdanik S, Dutkiewicz G, Borowiak K, Janus T (2011). Death caused by addictive inhalation of nitrous oxide. Hum Exp Toxicol 30: 1875-1877.
32. Schechter MD, Lovano DM (1985). Ethanol-chlordiazepoxide interactions in the rat. Pharmacol Biochem Behav 23:927-930. (Pubitemid 16178360)
33. Seidberg BH, Sullivan T (2004). Dentists' use, misuse, abuse or dependence on mood-altering substances. N Y State Dent J 70:30-33.
34. Shelton K, Balster R (1994). Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA antagonists. Behav Pharmacol 5 (4 and 5): 441-451.
35. Shelton K, Grant K (2002). Discriminative stimulus effects of ethanol in C57BL/6J and DBA/2J inbred mice. Alcohol Clin Exp Res 26:747-757. (Pubitemid 34666132)
36. Shelton K (2007). Inhaled toluene vapor as a discriminative stimulus. Behav Pharmacol 18:219-229. (Pubitemid 46624345)
37. Shelton K (2009). Discriminative stimulus effects of inhaled 1,1,1-trichloroethane in mice: comparison to other hydrocarbon vapors and volatile anesthetics. Psychopharmacology (Berl) 203:431-440.
38. Shelton K, Slavova-Hernandez G (2009). Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration. Pharmacol Biochem Behav 92:614-620.
39. Shelton K (2010). Pharmacological characterization of the discriminative stimulus of inhaled 1,1,1-trichloroethane. J Pharmacol Exp Ther 333:612-620.
40. Shelton K, Nicholson K (2010). GABA A positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice. Psychopharmacology (Berl) 212:559-569.
41. Shelton K, Nicholson K (2012). GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor. Drug Alcohol Depend 121:103-109.
42. Steffey E, Gillespie J, Berry J, Eger E, Munson E (1974). Anesthetic potency (MAC) of nitrous oxide in the dog, cat, and stump-tail monkey. J Appl Physiol 36:530-532.
43. Stolerman IP, Rauch RJ, Norris EA (1987). Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharmacology (Berl) 93:250-256. (Pubitemid 18013066)
44. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2008). The NSDUH Report: Inhalant Use across the Adolescent Years. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
45. Tomi K, Mashimo T, Tashiro C, Yagi M, Pak M, Nishimura S, et al. (1993). Alterations in pain threshold and psychomotor response associated with subanaesthetic concentrations of inhalation anaesthetics in humans. Br J Anesth 70:684-686. (Pubitemid 23169065)
46. Walker DJ, Zacny JP (2003). Bitonic dose-response functions for reinforcing and self-reported effects of nitrous oxide in humans. Pharmacol Biochem Behav 74:851-857. (Pubitemid 36351650)
47. York JL (1978). A comparison of the discriminative stimulus effects of ethanol, barbital, and phenobarbital in rats. Psychopharmacology (Berl) 60:19-23. (Pubitemid 9047368)
48. Zacny J, Sparacino G, Hoffmann P, Martin R, Lichtor J (1994). The subjective, behavioral and cognitive effects of subanesthetic concentrations of isoflurane and nitrous oxide in healthy volunteers. Psychopharmacology (Berl) 114:409-416. (Pubitemid 24153489)
49. Zacny J, Walker D, Derus L. (2008). Choice of nitrous oxide and its subjective effects in light and moderate drinkers. Drug Alcohol Depend 98:163-168.
50. Zancy J, Lichtor J, Coalson D, Alessi R, Goldsher G, Young C, et al. (1996). Examining the subjective, psychomotor and reinforcing effects of nitrous oxide in healthy volunteers: a dose-response analysis. Behav Pharmacol 7:194-199. (Pubitemid 26121375)